Literature DB >> 29718184

The pyrin inflammasome: from sensing RhoA GTPases-inhibiting toxins to triggering autoinflammatory syndromes.

Yvan Jamilloux1,2, Flora Magnotti1, Alexandre Belot1,3, Thomas Henry1.   

Abstract

Numerous pathogens including Clostridium difficile and Yersinia pestis have evolved toxins or effectors targeting GTPases from the RhoA subfamily (RhoA/B/C) to inhibit or hijack the host cytoskeleton dynamics. The resulting impairment of RhoA GTPases activity is sensed by the host via an innate immune complex termed the pyrin inflammasome in which caspase-1 is activated. The cascade leading to activation of the pyrin inflammasome has been recently uncovered. In this review, following a brief presentation of RhoA GTPases-modulating toxins, we present the pyrin inflammasome and its regulatory mechanisms. Furthermore, we discuss how some pathogens have developed strategies to escape detection by the pyrin inflammasome. Finally, we present five monogenic autoinflammatory diseases associated with pyrin inflammasome deregulation. The molecular insights provided by the study of these diseases and the corresponding mutations on pyrin inflammasome regulation and activation are presented.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29718184     DOI: 10.1093/femspd/fty020

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  19 in total

Review 1.  RHO GTPases: from new partners to complex immune syndromes.

Authors:  Rana El Masri; Jérôme Delon
Journal:  Nat Rev Immunol       Date:  2021-02-05       Impact factor: 53.106

Review 2.  Inflammasomes in the pathophysiology of autoinflammatory syndromes.

Authors:  Sarang Tartey; Thirumala-Devi Kanneganti
Journal:  J Leukoc Biol       Date:  2019-10-14       Impact factor: 4.962

Review 3.  The pyrin inflammasome in host-microbe interactions.

Authors:  Nicole A Loeven; Natasha P Medici; James B Bliska
Journal:  Curr Opin Microbiol       Date:  2020-02-28       Impact factor: 7.934

Review 4.  Effector-triggered immunity and pathogen sensing in metazoans.

Authors:  Natasha Lopes Fischer; Nawar Naseer; Sunny Shin; Igor E Brodsky
Journal:  Nat Microbiol       Date:  2019-12-19       Impact factor: 30.964

Review 5.  Therapeutic implications of inflammasome in inflammatory bowel disease.

Authors:  Vishal Khatri; Ramaswamy Kalyanasundaram
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.834

Review 6.  TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages.

Authors:  Harald Wajant; Daniela Siegmund
Journal:  Front Cell Dev Biol       Date:  2019-05-29

Review 7.  MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies.

Authors:  Gulcin Tezcan; Ekaterina V Martynova; Zarema E Gilazieva; Alan McIntyre; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  Front Pharmacol       Date:  2019-05-01       Impact factor: 5.810

Review 8.  RhoA as a Key Regulator of Innate and Adaptive Immunity.

Authors:  Matthias Bros; Katharina Haas; Lorna Moll; Stephan Grabbe
Journal:  Cells       Date:  2019-07-17       Impact factor: 6.600

Review 9.  Role of inflammasomes in the pathogenesis of periodontal disease and therapeutics.

Authors:  Julie T Marchesan; Mustafa Saadat Girnary; Kevin Moss; Eugenia Timofeev Monaghan; Grant Joseph Egnatz; Yizu Jiao; Shaoping Zhang; Jim Beck; Karen V Swanson
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

Review 10.  The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer.

Authors:  Man Wang; Shuai Jiang; Yinfeng Zhang; Peifeng Li; Kun Wang
Journal:  Cancers (Basel)       Date:  2019-09-05       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.